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DP-ribosylation factor (Arf) 6 regulates the movement
of membrane between the plasma membrane (PM)
and a nonclathrin-derived endosomal compartment
and  activates phosphatidylinositol 4-phosphate 5-kinase
(PIP 5-kinase), an enzyme that generates phosphatidylinositol
4,5-bisphosphate (PIP
 
2
 
). Here, we show that PIP
 
2 
 
visualized
by expressing a fusion protein of the pleckstrin homology
 
domain from PLC
 
 
 
 and green ﬂuorescent protein (PH-GFP),
colocalized with Arf6 at the PM and on tubular endosomal
structures. Activation of Arf6 by expression of its exchange
factor EFA6 stimulated protrusion formation, the uptake of
PM into macropinosomes enriched in PIP
 
2
 
, and recycling
of this membrane back to the PM. By contrast, expression
A
 
of Arf6 Q67L, a GTP hydrolysis-resistant mutant, induced
 
the formation of PIP
 
2
 
-positive actin-coated vacuoles that
were unable to recycle membrane back to the PM. PM
proteins, such as 
 
 
 
1-integrin, plakoglobin, and major
histocompatibility complex class I, that normally trafﬁc
through the Arf6 endosomal compartment became trapped
in this vacuolar compartment. Overexpression of human
PIP 5-kinase
 
 
 
 
 
 
 
mimicked the effects seen with Arf6 Q67L.
These results demonstrate that PIP 5-kinase activity and
PIP
 
2 
 
turnover controlled by activation and inactivation of
Arf6 is critical for trafﬁcking through the Arf6 PM-endosomal
recycling pathway.
 
Introduction
 
Cells interact with their environment at the plasma membrane
(PM)* and respond to stimuli by rearranging their surfaces
through modification of cell junctions, cell polarity, and the
organization of the cortical actin cytoskeleton. Although
signaling pathways and actin dynamics have well-documented
roles in these responses, the contribution of membrane
traffic to these processes is less clear. Nonetheless, evidence
is accumulating that the insertion and uptake of membrane
at the PM is important in regulating PM morphology
(Mellman, 2000). Requirements for membrane traffic in
neutrophil migration (Lawson and Maxfield, 1995) and
phagocytosis (Bajno et al., 2000) have been demonstrated.
Similarly, GTPases involved in the regulation of membrane
traffic, such as Rab5 (Spaargaren and Bos, 1999), Rab8
(Peranen et al., 1996), and ADP-ribosylation factor (Arf) 6
(Radhakrishna et al., 1996) have been shown to influence
cortical actin structure at the PM, lending support to the
concept that membrane trafficking can influence the com-
position and structure of the plasma membrane.
We have been studying the Arf6 GTPase in cells to elucidate
 
the relationship between Arf6-regulated membrane traffic
and cell morphology at the PM. In HeLa and many other
cells, Arf6 regulates the movement of membrane between
the PM and a nonclathrin-derived endosomal compartment
(Radhakrishna and Donaldson, 1997). PM proteins and
lipids that are internalized by this endocytic pathway can be
recycled back to the PM. This membrane recycling requires
activation of Arf6 and the presence of actin filaments
(Radhakrishna and Donaldson, 1997). Activation of Arf6
has also been implicated in regulated exocytosis (Galas et
al., 1997), suggesting that recycling of plasma membrane and
regulated exocytosis may be related or share some properties.
Several investigations have shown that Arf6-dependent
regulation of membrane recycling influences the actin cy-
toskeleton along the PM. Expression of a dominant negative
mutant of Arf6, T27N, that inhibits membrane recycling
inhibits cell spreading (Song et al., 1998), Rac-mediated
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ruffling (Radhakrishna et al., 1999), and Fc-mediated pha-
gocytosis (Zhang et al., 1998). Acute activation of Arf6 by
either treatment of cells with aluminum fluoride (AlF)
(Radhakrishna et al., 1996) or coexpression of guanine nu-
cleotide exchange factors (GEFs) for Arf6, ARNO (Frank et
al., 1998), or EFA6 (Franco et al., 1999) results in ruffling
protrusive structures along the PM. Although expression of
the constitutively active Arf6 mutant, Q67L, also generates
protrusive structures and alterations in cortical actin (Rad-
hakrishna et al., 1996), a variety of changes in cell mor-
phology is observed, and the phenotype has not been
explored thoroughly. Some studies investigating the mor-
phology of cells expressing Arf6 Q67L report extensive in-
vaginations of the PM, often tortuous and complex (Peters
et al., 1995; D’Souza-Schorey et al., 1998). In another re-
cent report, constitutively active Arf6 was shown to decrease
stress fiber formation, suggesting antagonism of Rho func-
tion (Boshans et al., 2000). The variable morphology of
cells expressing Arf6 Q67L can be attributed to the conse-
quence of persistent activation of Arf6 effectors over ex-
tended periods during transient transfection. Understand-
ing how activated Arf6 causes these morphological changes
would clarify the normal functions of Arf6 in cells.
An important advance in understanding Arf function was
the recent demonstration that members of the Arf family can
activate type I phosphatidylinositol 4-phosphate 5-kinase
(PIP 5-kinase), an enzyme that catalyses the formation of
phosphatidylinositol 4,5-bisphosphate (PIP
 
2
 
) from phos-
phatidylinositol 4-phosphate (Honda et al., 1999; Godi et
al., 1999; Jones et al., 2000). Synthesis and turnover of PIP
 
2
 
have been implicated in a variety of cellular events including
membrane trafficking (Martin, 1997), control of actin poly-
merization (Janmey, 1994; Yamamoto et al., 2001), regula-
tion of ion channel transporters (Kobrinsky et al., 2000), and
signal transduction where it serves as a substrate for enzymes
such as PLC and phosphatidylinositol 3-kinase (Czech,
2000). This pleiotropic role of PIP
 
2
 
 illustrates the impor-
tance of understanding where in the cell PIP
 
2 
 
is synthesized
and how this process is regulated spatially. Although all Arfs
have been shown to stimulate PIP 5-kinase activity in vitro,
Figure 1. Arf6 and PH-GFP colocalize 
at the PM and on distal portions of the 
tubular endosome. HeLa cells were 
cotransfected with Arf6 and PH-GFP and 
then incubated for 30 min with either no 
addition (Cont., top), 0.2  M CD (Cyto D, 
middle), or 30 mM NaF and 50  M 
AlCl3 (AlF, bottom) and then fixed and 
processed for immunofluorescence 
labeling of Arf6. Membrane internaliza-
tion into the Arf6 compartment during 
extended AlF treatment was assessed by 
examining uptake of Tac antibody in 
cells cotransfected with Arf6 and Tac 
(AlF 3 h, bottom). Asterisk denotes cell 
transfected with PH-GFP alone, displaying 
enhanced tubular localization after CD 
treatment. Bars, 10  m. 
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in cells it is Arf6 that colocalizes with PIP 5-kinase at the PM
(Honda et al., 1999). Protrusions and ruffles generated by
activation of Arf6 result in the recruitment of PIP 5-kinase
and PLD2 into the PM structures (Honda et al., 1999), sug-
gesting that Arf6 might function in cells through activation
of PIP 5-kinase. However, no data has been published show-
ing the distribution of these proteins and their lipid product,
PIP
 
2
 
, in this membrane trafficking pathway.
Here, we have investigated the effects of Arf6 activation
and PIP 5-kinase on the distribution and local formation of
PIP
 
2
 
 in order to better understand the role of this lipid in
the regulation of membrane traffic through the Arf6 path-
way. We find that the Arf6 PM-endosomal recycling path-
way can serve as a mechanism to regulate the availability and
activity of PIP 5-kinase and therefore PIP
 
2 
 
levels at the PM.
We show that activation of Arf6 by expression of its ex-
change factor, EFA6, allows for uptake and recycling of
membrane through this pathway, whereas expression of con-
stitutively active Arf6Q67L or PIP 5-kinase alters the traf-
ficking of membrane such that PM proteins enter the cell
and become trapped in PIP
 
2
 
-positive actin-coated vacuolar
structures. These results establish that Arf6-dependent regu-
lation of PIP 5-kinase and PIP
 
2
 
 levels and their localization
is crucial for proper regulation of trafficking through the
Arf6 PM-endosomal recycling pathway.
 
Results
 
To understand the relationship between Arf6 function and
PIP 5-kinase, we first compared the distribution of Arf6 and
PIP
 
2
 
 in cells under conditions where we could manipulate
trafficking through the Arf6-regulated recycling pathway
with pharmacologic reagents. To localize PIP
 
2
 
, we expressed a
chimeric protein of the pleckstrin homology domain of
PLC
 
  
 
coupled to the green fluorescent protein (PH-GFP),
previously characterized as a marker for membrane-associated
PIP
 
2 
 
(Varnai and Balla, 1998). We examined the cellular dis-
tribution of PIP
 
2
 
 by monitoring PH-GFP localization in cells
expressing wild-type Arf6 after treatment with cytochalasin D
(CD) or AlF to impose blocks in the recycling pathway.
Cells cotransfected with plasmids encoding PH-GFP and
wild-type Arf6 exhibited a remarkable colocalization of PH-
GFP with Arf6 along the plasma membrane, and some asso-
ciated with endocytic structures (Fig. 1). The Arf6 endoso-
mal compartment was more readily observed upon treatment
of cells with CD. Under these conditions, Arf6 and PIP
 
2
 
were observed on the tubular endosomes emanating from the
juxtanuclear region. These tubular endosomes have been
shown previously to represent the accumulation of endocy-
tosed membrane within the Arf6 recycling compartment,
since CD blocks return of this membrane back to the PM
(Radhakrishna and Donaldson, 1997). The PH-GFP showed
striking colocalization with Arf6-labeled tubules, especially
on their distal portions. Labeling of the tubular endosomes
with PH-GFP in response to CD treatment did not require
overexpression of Arf6, since it was observed in cells express-
ing endogenous levels of Arf6 (Fig. 1, Cyto D, asterisk).
Recruitment of PH-GFP to membrane was dependent on
fusion to an intact PH domain specific for PIP
 
2
 
. Much re-
duced PM labeling and no endosomal tubule localization
was observed with the phosphatidylinositol 3,4,5-trisphos-
phate–specific Btk PH domain–GFP chimera nor was any
membrane localization detected with GFP fused to the
R40L mutant of the PLC
 
 
 
 PH domain, a mutation that
abolishes PIP
 
2
 
 binding (Varnai and Balla, 1998; unpub-
lished data). Thus, PH-GFP serves as a marker for most of
the membrane trafficking pathway regulated by Arf6.
To investigate the role of PIP
 
2
 
 and PIP 5-kinase in Arf6
function, we activated Arf6 by incubation of cells with AlF
or by coexpression of an Arf6-specific GEF, EFA6. AlF
treatment of cells resulted in the formation of protrusive
structures along the cell’s edge and caused Arf6 and PH-
GFP to colocalize in these structures consistent with previ-
ous reports (Honda et al., 1999). During extended AlF
treatment up to 3 h, we observed protrusive structures and
increased amounts of endocytic vesicles associated with these
protrusions. In cells coexpressing Tac, the 
 
 
 
-subunit of the
interleukin 2 receptor and a marker for the Arf6 endosome
(Radhakrishna and Donaldson, 1997), these endosomes ac-
cumulated Tac antibody by internalization during the 3-h
AlF treatment (Fig. 1, bottom). We had previously observed
these macropinosomes during protrusion formation induced
by AlF treatment (Radhakrishna et al., 1996). During short
AlF treatment, these structures recycle membrane and fluid
back to the PM (Radhakrishna et al., 1996). However, on
Figure 2. EFA6 induces formation of PIP2-enriched protrusions 
and the appearance of PIP2-labeled endosomal structures. HeLa 
cells were transfected with plasmids encoding EFA6 and PH-GFP 
and then fixed (top and middle) or treated with CD (100 nM for 
30 min) before fixing (bottom). Bars, 10  m. 
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longer AlF activation as shown here these macropinosomes
tend to be more evident (Fig. 1, bottom).
As an alternative to AlF stimulation, we expressed EFA6
shown to be a specific GEF for Arf6 in in vitro assays and in
cells (Franco et al., 1999). The majority of cells expressing
EFA6 exhibited protrusions around the cell periphery where
EFA6 and PIP
 
2
 
 colocalized (Fig. 2). This phenotype could be
observed in 57% of cells at 20 h and increased to 76% at
44 h after transfection (Table I). In about 5% of the cells, vacu-
olar endocytic structures that were positive for EFA6 and
PH-GFP were observed in the central portion of the cells
and also associated with the protrusions (Fig. 2 and Table I).
However, this is an underestimate, since imaging of live cells
expressing EFA6 revealed that all cells forming protrusions
were undergoing active endocytosis and recycling (see Fig.
7). These endosomal membranes also contained endogenous
molecules that traffic through the Arf6 endosome such as
major histocompatibility complex class I (MHC I; see Fig. 6).
EFA6-induced protrusion formation was inhibited in cells
coexpressing the dominant negative mutant of Arf6, T27N
(unpublished data), indicating that endogenous Arf6 medi-
ates the effects of EFA6 as described previously (Franco et al.,
1999). CD treatment also inhibited protrusions and resulted
in localization of EFA6 on the tubular endosomal mem-
branes (Fig. 2, bottom) as observed for Arf6 in Fig. 1.
 
Accumulation of PIP
 
2
 
-positive vacuoles in cells 
expressing Arf6 Q67L and PIP 5-kinase
 
We next examined the distribution of PH-GFP in cells ex-
pressing the constitutively active mutant of Arf6, Q67L.
Previous attempts to understand the phenotype of cells ex-
pressing Arf6 Q67L have been hampered by the lack of a
clear characterization of the onset and nature of the mem-
brane traffic block imposed. These cells are somewhat pro-
trusive, although not particularly F-actin rich (Radhakrishna
et al., 1996), and often take on distorted cell morphology.
Furthermore, immunofluorescent localization of Arf6 is
poorly resolved in these cells (Peters et al., 1995; Rad-
hakrishna et al., 1996). We assessed the distribution of
PIP
 
2
 
 in cells expressing Arf6 Q67L after a 44-h transfection
and found that PH-GFP clearly labeled distinct membrane
structures in these cells (Fig. 3). The vacuoles, particularly
those in large clusters, were coated with actin and were in-
side the cells as labeling of the cell surface with fluorescent
lectin in fixed cells (shown in Fig. 3) or with the lipid dye,
DiI, in live cells (unpublished data) did not label these struc-
tures. These actin-coated, PH-GFP–labeled structures were
also observed in other cell types including BHK (unpub-
lished data) and Cos cells (see Fig. 8). However, induction
of PIP
 
2
 
-positive vacuoles was specific to Arf6 and was not
observed with Arf1. Expression of the constitutively active
Arf1 mutant, Q71L, which stably associates with the Golgi
complex and causes alterations in Golgi morphology (Zhang
 
Table I. 
 
Percentage of cells exhibiting morphology
Protrusions only Vacuoles only Protrusions and vacuoles
 
20 h
PH-GFP alone 3.3 (2.2) 1.1 (1.3) 0
plus EFA6 53.8 (8.7) 2.5 (0.8) 3.5 (1.9)
plus
 
 
 
Arf6 Q67L 4.2 (1.8) 56.2 (9.5) 5.8 (1.9)
plus
 
 
 
PIP 5-kinase 0.1 (0.1) 36.1 (2.6) 1.1 (0.7)
44 h
PH-GFP alone 2.8 (2.3) 1.4 (0.4) 0
plus
 
 
 
EFA6 68.2 (5.6) 3.6 (0.1) 8.3 (2.1)
plus
 
 
 
Arf6 Q67L 2.1 (1.4) 71.9 (3.9) 8.1 (2.8)
plus
 
 
 
PIP 5-kinase 0 51.7 (3.3) 1.1 (1.4)
Numbers are displayed as average with SEM shown in parentheses. 200 cells clearly expressing the indicated protein(s) were counted per experiment.
Vacuoles were scored by observation of intracellular PIP
 
2
 
-positive ring-like structures. Data are representative of at least three independent experiments.
Figure 3. Constitutively active Arf6 induces the accumulation of 
PIP2-positive actin-coated vacuoles. HeLa cells were transfected 
with Arf6 Q67L and PH-GFP for 44 h and then fixed and probed 
with antibody to Arf6 (top), with phalloidin (middle), or the surface 
was stained using Alexa 594–conjugated concanavalin A (bottom). 
Bars, 10  m. 
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et al., 1994), did not induce the formation of PIP
 
2
 
-positive
vacuoles nor did the PH-GFP construct label the Golgi
complex (unpublished data).
The vacuolar membranes accumulated integral and pe-
ripheral membrane proteins that traffic through the Arf6 en-
dosome in untransfected cells. As can be seen in Fig. 4,
MHC I, 
 
 
 
1-integrin, and plakoglobin (
 
 
 
-catenin) were all
enriched in the PH-GFP–labeled structures induced by ex-
pression of Arf6 Q67L. The normal distribution of these
proteins in cells not expressing Q67L can also be observed
(Fig. 4). In contrast, transferrin receptor distribution in cells
expressing Q67L was similar to that in untransfected cells,
and transferrin receptor was absent from these vacuolar
structures, consistent with the distinction between the clath-
rin-coated and Arf6-regulated endocytic recycling systems
in HeLa cells as observed previously (Radhakrishna and
Donaldson, 1997).
The PH-GFP labeling of the vacuoles that accumulate in
cells expressing Arf6 Q67L suggests the involvement of PIP
 
2
 
and therefore a type I PIP 5-kinase in Arf6 function. Over-
expression of human PIP 5-kinase 
 
 
 
 (homologue of the
mouse PIP 5-kinase 
 
 
 
) alone resulted in cells containing vac-
uolar structures that were indistinguishable from those
formed in cells expressing Arf6 Q67L. The vacuoles labeled
with PH-GFP were actin coated and within the cell (Fig. 5).
These vacuoles were also formed in Cos cells expressing PIP
5-kinase (see Fig. 7). Kinase activity was necessary for the
formation of vacuoles, since expression of a PIP 5-kinase
mutant, D270A, which lacks kinase activity (Mejillano et
al., 2001), did not induce their formation (unpublished
data). Vacuoles induced in cells expressing human PIP
5-kinase labeled with antibodies to MHC I, integrins, and
plakoglobin but not with antibodies to the transferrin recep-
tor (unpublished data) similar to that observed for the ex-
pression of Arf6 Q67L (Fig. 4). Induction of vacuoles by
PIP 5-kinase appeared to occur downstream of Arf6 activa-
tion, since expression of dominant negative Arf6 did not
block vacuole formation (unpublished data). Furthermore,
at low expression levels barely detected by antibody PIP
5-kinase had no effect on cell morphology but could syner-
Figure 4. Overexpression of Arf6 Q67L traps proteins that traffic 
through the Arf6 compartment but not the transferrin receptor 
into PIP2-positive vacuoles. HeLa cells were transfected with Arf6 
Q67L and PH-GFP and probed with antibodies against MHC I, 
 1-integrin, plakoglobin, and the transferrin receptor as shown. 
Bars, 10  m.
Figure 5. Overexpression of PIP 5-kinase induces the accumula-
tion of PIP2-positive actin-coated vacuoles. HeLa cells were 
cotransfected with PIP 5-kinase and PH-GFP for 44 h, fixed, and 
probed with myc antibody to detect PIP 5-kinase (top), with 
phalloidin (middle), and the surface was stained using Alexa 594–
conjugated concanavalin A (bottom). Bars, 10  m. 
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gize with wild-type Arf6 to form protrusive structures (un-
published data). In contrast to the results with human PIP
5-kinase 
 
 
 
, expression of the mouse 
 
 
 
 isoform used by
Honda et al. (1999), a homologue of human PIP 5-kinase 
 
 
 
,
was less effective at inducing the vacuolar structures, although it
synergized with Arf6 to form protrusions (unpublished data).
 
PIP2 vacuoles are endosomally derived
 
To further characterize the nature of the vacuoles observed
in cells expressing EFA6 and Arf6 Q67L, we examined
whether these structures could be loaded with membrane
from the cell surface. Since MHC I is a marker for the Arf6
endosomal pathway (Radhakrishna and Donaldson, 1997),
we used antibody internalization over 30 min to test
whether surface MHC I can enter the cell and be delivered
to the PIP
 
2
 
 vacuoles. In cells expressing EFA6, antibody to
MHC I was observed in many of the PIP
 
2
 
-positive vacuoles
and macropinosomes observed at both 20 and 44 h of ex-
pression (Fig. 6). In cells expressing Arf6 Q67L, MHC I an-
tibody was found loaded into small PIP
 
2
 
-positive endosomal
structures in cells after a 20-h transfection (Fig. 6). How-
ever, at 44 h no uptake of MHC I was observed in cells ex-
pressing Arf6 Q67L where large vacuolar membranes were
apparent. It should be noted that at 20 h some cells that
contain numerous large vacuolar structures did not take up
antibody, suggesting that as internal membranes accumulate
the cells stop internalizing membrane. Although endocytosis
through the Arf6 pathway is apparently blocked at this late
stage, endogenous (steady-state) MHC I was observed in
these vacuolar structures (Fig. 4), presumably having been
internalized earlier in transfection. These observations dem-
onstrate that EFA6-induced vacuoles readily labeled with
MHC I from the PM, whereas Arf6 Q67L-induced vacuoles
could be labeled with surface antibody early but not at later
times in transfection.
 
Arf6 activation and membrane dynamics
 
To understand the dynamics of membrane trafficking and
the effects of expressing EFA6, Arf6 Q67L, or PIP 5-kinase
on membrane movement, live cells expressing PH-GFP were
imaged. As the bulk of PH-GFP–labeled endosomes appear
to be identical to the Arf6 recycling membrane compart-
ment (Fig. 1), the PH-GFP can be used as a probe to moni-
tor membrane traffic throughout the Arf6 pathway. Here,
we show images taken of transfected Cos cells 20 h after
transfection, since their more flattened appearance facili-
tated image acquisition. Similar observations were made in
HeLa cells. In Cos cells expressing PH-GFP alone, the edge
of the cells was quiet with little ruffling activity (Fig. 7 A).
Internal structures labeled with PH-GFP consisted of some
vesicular structures and membranous tubules. The tubules
could be seen moving throughout the cytoplasm along cur-
vilinear tracts, sometimes appearing to fuse with the PM
(Fig. 7 A; video 1 available at http://www.jcb.org/content/
vol154/issue5/1007). Cells coexpressing EFA6 and PH-
GFP exhibited extensive ruffling and protrusion activity at
the peripheral edge of the cells (Fig. 7 B; video 2). Along
with the ruffling, these cells internalized membrane via mac-
ropinocytosis, and these PH-GFP–labeled internal struc-
tures were observed forming and disappearing again. The
addition of CD to these cells immediately halted ruffling ac-
tivity, and internal PIP
 
2
 
-labeled endosomes extended tu-
Figure 6. Surface MHC I is internalized and gains access to PIP2 vacuoles in cells expressing EFA6 at all times but is only loaded into cells 
expressing Arf6 Q67L early in transfection. Hela cells were transfected with PH-GFP and EFA6 or Arf6 Q67L. At the indicated time (20 or 44 h), 
they were allowed to internalize MHC I antibody for 30 min and then were fixed and processed for visualizing internalized antibody. (Inset) 
Enlargement of box showing MHC antibody internalized into PIP2-positive macropinosomes. Bars, 10  m. 
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bules (unpublished data), resembling the appearance of
EFA6-expressing HeLa cells treated with CD (Fig. 2, bot-
tom row). In Fig. 7 B (video 2), some of the membrane ap-
peared to be discharged through tubules extending from
crescent-shaped wave-like structures along the ventral sur-
face of the cells. These waves are strongly induced by EFA6
expression (Fig. 2) and after serum stimulation (see Fig. 7 E;
video 5) and are found to a lesser extent in cells expressing
PH-GFP alone. However, over the course of the 40-min im-
aging period it was notable that cells expressing EFA6 con-
tinued to protrude and take in PM, indicating that mem-
brane recycling back to the PM was occurring. In contrast,
there was an increase in the number and size of vacuoles that
label with PH-GFP in cells expressing Arf6 Q67L over the
40-min time period of imaging (Fig. 7 C; video 3). At the
start of imaging, these Arf6 Q67L cells exhibited modest
ruffling and contained small vesicles and tubulo-vesicular
structures. However, over time vacuoles accumulated within
the cell, arising through an increase in both the numbers and
size of the vesicles. Indeed, the larger vacuoles appeared to be
forming through fusion of small vesicles. By the end of im-
aging, the cell was filled with vacuoles that often aggregated
to one side, and little ruffling was observed along the PM.
Cells expressing PIP 5-kinase underwent a similar transition,
resulting in the accumulation of vacuoles that increased in
number and size (Fig. 7 D; video 4). However, at early time
points it was notable that numerous tubules that labeled
with PH-GFP were present throughout the cell. The num-
ber and extent of these tubules diminished over time, since
the amount of membrane contained in the PH-GFP–labeled
vacuoles accumulated.
It is clear from the videos (available at http://www.
jcb.org/content/vol154/issue5/1007) that stimulation of
Arf6 activation influences the trafficking through and ap-
pearance of the Arf6 endosome and recycling pathway. Ex-
pression of EFA6 activates Arf6 but also allows for inacti-
vation; therefore, the cells ruffle and take in membrane via
macropinocytosis that is recycled, allowing continuous
protrusion activity. To demonstrate that this ruffling activ-
ity could be observed in cells not overexpressing EFA6, we
imaged serum-starved Cos cells expressing PH-GFP after
readdition of serum (Fig. 7 E). In the absence of serum, the
cells were not ruffling nor undergoing macropinocytosis,
but within minutes after serum addition active ruffling and
accumulation of macropinosomes in the cells were evident
(Fig. 7 E; video 5). Again, as in Fig. 7 B and video 2, mac-
ropinosomes coming into the cell were turned over during
the course of the video, and dissipation of membrane was
observed via tubules and wave-like structures along the
ventral surface.
 
Discussion
 
In this study, we provide evidence that Arf6 regulation of
membrane traffic is coupled to PIP
 
2
 
 generation and removal.
Under normal growth conditions, Arf6 constitutively under-
 
video shows the time points between the still images, are played 
at equivalent frame rates, and were recorded over the same 
approximate length of time. Bars, 10 
 
 
 
m.
 
Figure 7.
 
Live cell dynamics of PIP
 
2
 
-labeled membranes after Arf6 
activation.
 
 Cos cells were transfected with PH-GFP alone (A), EFA6 
(B), or Arf6 Q67L (C) or PIP 5-kinase (D) and then imaged 18 h after 
transfection for 
 
 
 
40 min. For serum add-back (E), PH-GFP–expressing 
cells were serum starved overnight. Serum (20%) was added imme-
diately before imaging. Images of the subject cells taken at 0 and 40 
min are shown. See also QuickTime videos 1–5 of each condition 
available at http://www.jcb.org/content/vol154/issue5/1007. Each  
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goes activation and inactivation, allowing membrane to recycle
into and out of the cell (Fig. 8). Although activation of Arf6
was stimulated by overexpression of EFA6, membrane was in-
ternalized into PIP
 
2
 
-labeled macropinosomes induced by pro-
trusive activities in these cells, but importantly, since Arf6
could be inactivated by an Arf GTP hydrolysis-activating pro-
tein, this membrane was efficiently recycled back to the PM to
allow continual rounds of protrusions and membrane traffic.
By contrast, overexpression of Arf6 Q67L, a GTP-hydrolysis–
resistant mutant of Arf6, resulted in the internalization and
trapping of membrane in PIP
 
2
 
-positive and actin-coated vacu-
olar structures. The vacuoles became enlarged from fusion of
smaller PIP
 
2
 
-labeled structures (Fig. 7 C; video 3). Overexpres-
sion of PIP 5-kinase induced an essentially identical morphol-
ogy, suggesting that it is the Arf6-GTP–stimulated PIP 5-kinase
activity and therefore elevated PIP
 
2 
 
which induces the block in
membrane trafficking. Together, these data show that inactiva-
tion of Arf6 and subsequent loss of PIP
 
2
 
 is an obligate step dur-
ing normal trafficking from this compartment (Fig. 8).
The formation of these vacuolar structures represents a
new aspect of constitutively active Arf6 phenotype not ap-
preciated previously. EM studies have suggested that the sur-
face of cells expressing Arf6 Q67L consists of numerous
membrane folds that label in HEK 293 cells with extracellu-
lar tracers (D’Souza-Schorey et al., 1998). The vacuoles we
observed in HeLa and Cos cells were often clustered to-
gether and positioned directly below the PM and from our
imaging and surface labeling studies appear to be separated
from the PM. Whether Arf6 Q67L acts at the PM or imme-
diately after endocytosis may vary with cell type. Previously,
we reported that internalization into the Arf6 recycling com-
partment was blocked in HeLa cells expressing Arf6 Q67L
36–40 h after transfection (Radhakrishna and Donaldson,
1997). In the present study, we find that by 44 h 80% of the
cells already contain large accumulations of vacuoles (Fig.
3), and in these cells antibody internalization from the cell
surface is greatly inhibited (Fig. 6). However, at earlier times
in transfection there are many cells with small PIP
 
2
 
-labeled
endosomes that can internalize antibody into the forming
vacuoles (Fig. 6 and Fig. 7 C; video 3 available at http://
www.jcb.org/content/vol154/issue5/1007).
The clear labeling of the vacuoles with PH-GFP and the
ability to image cells expressing Arf6 Q67L during the onset of
vacuole formation has assisted us in elucidating the alteration
in membrane trafficking induced by this active mutant. We do
not know why the onset of the Arf6 Q67L phenotype occurs
for different cells at different times such that at 20 h after trans-
fection there are a few cells already loaded with vacuoles. What
is clear is that once vacuoles accumulate within the cell, en-
docytosis via the nonclathrin pathway is greatly reduced, pre-
sumably as a mechanism to maintain the cell surface area.
Our studies implicate PIP
 
2
 
 and the ability to generate and
remove PIP2 as being critical for maintaining trafficking
through the Arf6 endosomal recycling pathway. However,
we have not been able to demonstrate directly this biochem-
ically in intact cells. A plausible explanation for this is that
PIP2 increases may occur in small microdomains on mem-
branes that would be difficult to measure but that neverthe-
less could influence membrane activities such as the fusion
and generation of PIP2-labeled vacuoles observed here.
The trafficking block imposed by overexpression of PIP 5-
kinase and the accumulation of PIP2-positive actin-coated
endosomal structures observed here may be related to phe-
notypes observed in cells from mice in which PIP2 5-phos-
phatases, which reduce PIP2 levels, have been eliminated.
For example, clathrin-coated vesicles accumulate in nerve
terminals of mice lacking synaptojanin (Cremona et al.,
1999). Moreover, a recent study describing enlarged actin-
coated vacuolar membranes in sertoli cells from mice lacking
another PIP2 5-phosphatase, InPP5b, may be more directly
related to the phenotype observed here (E. Hellsten and R.
Nussbaum, personal communications).
Arf6 functions through PIP 5-kinase
Our results are consistent with an earlier report that showed
that PIP 5-kinase is a significant downstream effector of Arf6.
Studies by Honda et al. (1999) identified Arf proteins as acti-
vators of PIP 5-kinase in vitro, and their in vivo studies also
suggested that PIP 5-kinase is a mediator of Arf6 functions in
cells (Honda et al., 1999). The observation made here that
overexpression of PIP 5-kinase can induce the same morpho-
logical changes as activated Arf6 and that these effects are not
blocked by expression of the dominant negative mutant of
Arf6 indicates that PIP 5-kinase indeed acts downstream of
Arf6-GTP. The high level expression of PIP 5-kinase may re-
sult in increased PIP2 such that there is no affect of dominant
negative Arf6. Furthermore, in our studies low level expres-
sion of PIP 5-kinase with wild-type Arf6, conditions under
which neither one alone has any effect, synergizes to induce
Figure 8. Model for the roles of PIP 5-kinase and PIP2 on Arf6-
regulated membrane traffic. Under normal growth conditions 
(Constitutive, bottom half), membrane is transported from the tubular 
endosome and fuses with the plasma membrane in an Arf6-GTP–
dependent step that activates PIP 5-kinase. Upon internalization 
from the plasma membrane, GTP on Arf6 is hydrolyzed, generating 
Arf6-GDP, allowing PIP2 levels to be lowered. The membrane fuses 
with the recycling endosome and then returns to the PM completing 
the cycle. When GEF activity is elevated, as in overexpression of 
EFA6 (Stimulated, top half) or transiently upon addition of serum to 
serum-starved cells, protrusions are formed. This leads to the uptake 
of membrane into dynamic PIP2-positive macropinosomes that can 
rapidly turn over, since Arf6-GTP can be converted to Arf6-GDP, 
allowing PIP2 levels to decrease and sorting through the recycling 
endosome to proceed. However, expression of Arf6Q67L or PIP
5-kinase results in an accumulation of PIP2 endosomes that tether to 
and fuse with one another, forming large vacuolar membrane 
structures (dotted arrow), preventing membrane from recycling back 
to the PM.PIP2 and Arf6-regulated membrane traffic | Brown et al. 1015
protrusions similar to AlF-induced membrane accumula-
tions. The morphological data presented here together with
the biochemical evidence of Honda et al. (1999) suggests that
Arf6-GTP can bind to and activate PIP 5-kinase in cells,
leading to locally elevated PIP2.
The overexpressed PIP 5-kinase localizes to the PM, and
at low levels of expression it is observed on the Arf6 recy-
cling compartment, especially when recycling is blocked
with CD. Furthermore, the localization of PIP 5-kinase to
these membranes is independent of the nucleotide status
of Arf6 (unpublished data). Our data suggests that PIP
5-kinase activity is responsible for mediating trafficking
through the Arf6 pathway and that the level of PIP 5-kinase
activity is regulated by the nucleotide status of Arf6.
Previous reports on overexpression of PIP 5-kinase have
focused on changes to the actin cytoskeleton such as forma-
tion of stunted actin filaments (Shibasaki et al., 1997), mi-
crovilli (Matsui et al., 1999), stress fibers (Yamamoto et al.,
2001), and exocytic and endocytic vesicles propelled by ac-
tin rockets (Rozelle et al., 2000). We have focused on the in-
fluence of PIP 5-kinase expression on membranes and sug-
gest that the effects of PIP 5-kinase in the earlier studies and
in our report may be related. We occasionally observed rock-
eting PIP2-labeled vesicles that extended out from the PM as
microvillar-like projections in cells expressing PIP 5-kinase
(Fig. 7 D; video 4 available at http://www.jcb.org/content/
vol154/issue5/1007) like those of Rozelle et al. (2000). In-
terestingly, Schafer et al. (2000) have now reported that mi-
croinjection of Arf6 Q67L into cells induces the formation
of actin comet tails on endocytic vesicles. These rocketing
endosomes may represent an early step that precedes vacuole
formation and the block in membrane traffic. Indeed, they
may fuse with each other to generate the vacuoles that we see
developing at later times in HeLa and Cos cells.
Cellular functions of Arf6-generated PIP2
The ability of Arf6 to modulate PIP2 levels and regulate traf-
ficking of critical PM proteins could serve several cellular
processes that involve changes in PM architecture. The trap-
ping of proteins involved in cell adhesion into Arf6 vacuoles
observed in cells expressing Arf6 Q67L or PIP 5-kinase (Fig.
4) had an effect on adhesion and morphology of these cells
after 24–40 h, resulting in a reduced footprint on the
substratum (unpublished data). Zhang et al. (1998) have
reported that Fc-mediated phagocytosis in macrophages
requires Arf6 function. Both constitutively active and dom-
inant negative Arf6 mutants blocked phagocytosis, show-
ing that Arf6 must complete GTP-GDP cycling for particle
internalization. Consistent with this and our data, gen-
eration and removal of PIP2 has been shown recently to be
crucial for phagocytosis. PIP2 levels are transiently enhanced
beneath the phagocytic cup before internalization and then
return to normal PM levels most likely through stimulation
of PLC as the particle is engulfed (Seastone et al., 1999;
Botelho et al., 2000). Together with our studies, this sug-
gests that Arf6 and PIP 5-kinase must be activated to in-
crease PIP2 and then inactivated to facilitate PIP2 removal in
order for the engulfment phase of internalization to occur.
Additionally, several studies have implicated turnover of var-
ious phosphoinositides including PIP2 during macropinocy-
tosis (Amyere et al., 2000; Malecz et al., 2000), raising the
possibility of a role for Arf6 in this process. Finally, there is
an intriguing parallel between the formation and fusion of
PIP2 vesicles in our system and the role of PIP2 during yeast
vacuole fusion where PIP2 is required during tethering and
fusion of vacuoles (Mayer et al., 2000). In both cases, larger
vacuoles formed as a result of the association and fusion of
small vesicles.
At the molecular level, formation and turnover of PIP2
could facilitate the recruitment and activities of numerous
proteins. Indeed PIP2 and PIP3 have been shown both to re-
cruit and regulate the activity of proteins that regulate mem-
brane traffic such as Arf GEFs and GT hydrolysis-activating
protein (Toker, 1998). Thus the generation of PIP2 at spe-
cific sites followed by its rapid removal may provide a mech-
anism for spatial and temporal regulation by controlling the
recruitment and activity of proteins involved in these pro-
cesses (Martin, 1998).
Parallel roles for Arfs at the plasma membrane and 
the Golgi complex
The activities associated with Arf6 at the plasma membrane
are related to those observed for Arf1 at the Golgi complex.
Arf1-regulated membrane traffic and the assembly of cytosk-
eletal elements onto the Golgi complex is facilitated by Arf1-
dependent binding of coat protein complexes to Golgi
membranes and through Arf1-stimulated changes in lipid
composition at Golgi membranes (Donaldson and Jackson,
2000). In addition to PIP 5-kinases, PI 4-kinases can also
contribute to the formation of PIP2, and Arf1 has been
shown to recruit a PI 4-kinase to Golgi membranes, which
results in an increase in PIP2 levels (Stamnes et al., 1998;
Godi et al., 1999; Jones et al., 2000). Arf1 can recruit actin
and spectrin to Golgi membranes, possibly through PIP2-
enriched domains on Golgi membranes (Godi et al., 1998;
Fucini et al., 2000). Importantly, for both Arf1 and Arf6 the
ability of these GTPases to cycle between active and inactive
forms is crucial for their ability to regulate membrane traffic
and structure in cells.
An emerging theme in the function of Arf family mem-
bers is regulation of membrane lipid composition. Here,
we have demonstrated that Arf6 controls traffic through a
clathrin-independent PM/endosomal pathway by regulating
PIP2. Localized transient activation of Arf6 and therefore el-
evation of PIP2 levels can regulate membrane traffic and PM
morphology during cellular processes such as phagocytosis
and cell migration. Understanding how members of the Arf
family regulate these pathways and how this contributes to
membrane traffic presents a major challenge in cell biology.
Materials and methods
Cells, reagents, and antibodies
Cos, BHK, and HeLa cells were grown in DME supplemented with 10%
FBS, 100 U/ml penicillin, and 100  g/ml streptomycin at 37 C with 5%
CO2. Rabbit polyclonal antibodies were used as described previously
(Radhakrishna and Donaldson, 1997). Mouse monoclonal antibody
(16B12) against the influenza HA epitope was purchased from BabCo.
Mouse monoclonal antibody (9E10) against the myc epitope was pur-
chased from Zymed Laboratories. Human Tac antigen (IL-2 receptor   sub-
unit) was detected with mouse monoclonal anti-Tac antibodies (7G7). Tac
uptake was performed as described previously (Radhakrishna and Donald-1016 The Journal of Cell Biology | Volume 154, 2001
son, 1997). Mouse hybridoma cells generating antibodies against human
MHC I W6/32 were provided by Dr. Paul Roche (National Institutes of
Health). Alexa 594 concanavalin A and secondary antibodies (Alexa 594,
Alexa 488, anti–mouse, and anti–rabbit) were from Molecular Probes, Inc.
All other reagents including M5 anti-FLAG antibody and TRITC-phalloidin
were purchased from Sigma-Aldrich.
DNA manipulations and transient transfections
EFA6 was cloned from Marathon human fetal brain cDNA library (CLON-
TECH Laboratories, Inc.) by PCR and then shuttled into pFLAG-cmv6
(Sigma-Aldrich), placing the FLAG epitope on the NH2 terminus of the pro-
tein. EFA6 sequence was confirmed correct by sequencing. Wild-type and
mutant Arf6 genes were shuttled from pXS into pCDNA3.1. Identical results
were achieved using Arf6 genes in either vector. myc-tagged human type I
PIP 5-kinase   was as described previously (Rozelle et al., 2000). The PH
domain from PLC 1 cloned into pEGFP-N1 for use as a high affinity marker
for PIP2 was described previously (Varnai and Balla, 1998). This fusion pro-
tein can associate with soluble inositol 1,4,5-trisphosphate (Hirose et al.,
1999); however, when membrane bound it specifically recognizes PIP2
among phosphoinositides. At high expression levels, PH-GFP can interfere
with activities requiring PIP2 through sequestration (Raucher et al. 2000),
and we observed increased blebbing in cells expressing high levels of PH-
GFP. However, low level expression of the chimera as used here is a useful
indicator of PIP2 distribution (Botelho et al., 2000; Tall et al., 2000).
HeLa cells were grown on glass coverslips and transfected using the cal-
cium phosphate method as described previously (Bonifacino et al., 1989)
or Fugene 6 (Roche) according to the manufacturers instructions. Typi-
cally, the cells were then examined the following day ( 20 h) or the sec-
ond day ( 44 h) after DNA addition.
MHC I antibody internalization
Serum-containing medium with MHC monoclonal antibody (clone W6/32)
was preequilibrated to 37 C for 30 min before addition of cells. Cells were
allowed to internalize antibody for 30 min and then fixed. To mask anti-
body bound to the cell surface, cells were probed with unconjugated goat
anti–mouse antibody in the absence of saponin for 30 min and then re-
fixed briefly. Internalized MHC antibody was then visualized by probing
with Alexa 594–conjugated GAM in the presence of saponin.
Microscopy
Either 20 or 44 h after transfection, cells were treated as indicated, fixed
with 2% formaldehyde in PBS for 10 min at room temperature, and rinsed
with 10% FBS and 0.02% azide in PBS (PBS/serum). Cells were incubated with
primary antibodies diluted in PBS/serum containing 0.2% saponin for 1 h
at room temperature and then washed (three times for 5 min each) with
PBS/serum. The cells were then incubated with fluorescently labeled sec-
ondary antibodies diluted in PBS/serum plus 0.2% saponin for 1 h, washed
again, and mounted on glass slides. Note that the onset of the phenotype
occurs after overnight (20-h) transfection. However, cells were frequently
fixed at 44 h when more cells exhibited the phenotype. Images were taken
on a ZEISS 510 laser scanning microscope using a 63  1.3 NA PlanApo
objective. Figures were constructed using Adobe Photoshop
® 5.5. For live
cell imaging, Cos cells were plated in Lab-tek coverglass chambers with
glass of no. 1 thickness (Nunc). Cells were cultured overnight, transfected
the following day, and then imaged after a further 20 h. 25 mM Hepes, pH
7.4, was added to maintain pH while the chamber was on the microscope.
Online supplemental material
Live cell images shown in Fig. 7 were acquired at 37 C every 10 s. In each
case, images were acquired over a period of  40 min at 20 h after trans-
fection. Videos were generated with Adobe Premiere
®, using every third
frame due to file size constraints. Videos are played at rates such that tim-
ing is comparable between each condition. Videos 1–5 are available at
http://www.jcb.org/content/vol154/issue5/1007.
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